Thursday 10 June 2021
Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021
Bharat Biotech said there were nine publications on Covaxin so far and the efficacy paper of phase-3 trials would be the tenth one.
from Top Business News- News18.com
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment